IPD's specialized trackers cover the global pharma market, including supplementary protection certificates (SPCs), country-specific regulatory exclusivities, and ongoing litigation, such as oppositions, infringements, and trials for invalidation across the globe, for improved:

​

• Competitive intelligence

• Market access strategy

• Brand, generic, and biosimilar launch projections

• Global clinical pipeline tracking

• Loss-of-exclusivity analysis and forecasting

• Identification of gaps in the marketplace

• Drug life-cycle management strategies

• Litigation-outcome forecasting

• Ongoing and historical litigation event tracking

• Patent protection monitoring

• API (DMF) information